1) Levy, D et al:Long-term trends in the incidence of and survival with heart failure. N Engl J Med 2002;347:1397-1402
2) Camici, PG et al:Stunning, hibernation, and assessment of myocardial viability. Circulation 2008;117:103-114
3) Tamaki, N ed:Cardiovascular molecular imaging. Eur J Nucl Med Mol Imaging 2007;34 (Suppl 1) :S1-S104
4) Bax, JJ et al:Radionuclide techniques for the assessment of myocardial viability and hibernation. Heart 2004;90:v26-v33
5) Beanlands, R et al:Myocardial viability. Principles and Practice of PET and PET/CT, Wahl, RL ed, Lippincott Williams & Wilkins, Philadelphia, 2009, 565-588
6) Rahimtoola, SH:The hibernating myocardium. Am Heart J 1989;117:211-221
7) Wijns, W et al:Hibernating myocardium. N Engl J Med 1998;339:173-181
8) Braunwald, E et al:The stunned myocardium:prolonged, postischemic ventricular dysfunction. Circulation 1982;66:1146-1149
9) Gerber, BL et al:Positron emission tomography using 18F-fluoro-deoxyglucose and euglycaemic hyperinsulinaemic glucose clamp:optimal criteria for the prediction of recovery of post-ischaemic left ventricular dysfunction. Results from the European Community Concerted Action Multicenter study on use of 18F-fluoro-deoxyglucose Positron Emission Tomography for the Detection of Myocardial Viability. Eur Heart J 2001;22:1691-1701
10) vom Dahl, J et al:Relation of regional function, perfusion, and metabolism in patients with advanced coronary artery disease undergoing surgical revascularization. Circulation 1994;90:2356-2366
11) Tamaki, N et al:Prediction of reversible ischemia after revascularization. Perfusion and metabolic studies with positron emission tomography. Circulation 1995;91:1697-1705
12) Bax, JJ et al:Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease:comparison of pooled data. J Am Coll Cardiol 1997;30:1451-1460
13) Bax, JJ et al:Delayed recovery of hibernating myocardium after surgical revascularization:implications for discrepancy between metabolic imaging and dobutamine echocardiography for assessment of myocardial viability. J Nucl Cardiol 1999;6:685-687
14) Bax, JJ et al:Time course of functional recovery of stunned and hibernating segments after surgical revascularization. Circulation 2001;104:I-314-I-318
15) Udelson, JE:Steps forward in the assessment of myocardial viability in left ventricular dysfunction. Circulation 1998;97:833-838
16) Klocke, FJ et al:ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging-executive summary:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines(ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging). J Am Coll Cardiol 2003;42:1318-1333
17) Samady, H et al:Failure to improve left ventricular function after coronary revascularization for ischemic cardiomyopathy is not associated with worse outcome. Circulation 1999;100:1298-1304
18) Allman, KC et al:Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction:a meta-analysis. J Am Coll Cardiol 2002;39:1151-1158
19) Hachamovitch, R et al:Impact of ischaemia and scar on the therapeutic benefit derived from myocardial revascularization vs. medical therapy among patients undergoing stress-rest myocardial perfusion scintigraphy. Eur Heart J 2011;32:1012-1024
20) Tonino, PA et al:Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med 2009;360:213-224